The University of Birmingham is committed to being at the vanguard of academic-led drug discovery and the search for the next generation of therapies that will benefit humankind. Recently, the University of Birmingham has invested nearly three quarters of a million pounds to develop a High-Throughput Screening (HTS) facility. The Birmingham Drug Discovery Facility contains a number of cutting-edge technologies required to enable Birmingham scientists to conduct translational science.

We offer access to two fully automated drug discovery platforms  housed in the Drug Discovery Facility laboratory which is located in the School of Biosciences at the Institute of Microbiology and Infection (IMI).